Who owns the POSIDRAX trademark?

The POSIDRAX trademark is owned by Vicuron Pharmaceuticals Inc..

What is the serial number for POSIDRAX?

The USPTO serial number for POSIDRAX is 78278632.

What is the registration number for POSIDRAX?

POSIDRAX is registered under USPTO registration number 0.

POS

USPTO Trademark Record

ABANDONED

POSIDRAX

Q: What class is the POSIDRAX trademark registered in?

The POSIDRAX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 78278632·Reg 0·Filed Jul 24, 2003

Owner Vicuron Pharmaceuticals Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

POSIDRAX (Serial No. 78278632), Registration No. 0, is a abandoned US trademark filed on Jul 24, 2003 by Vicuron Pharmaceuticals Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

POSIDRAX (Reg. #0) is an abandoned US trademark that was filed in 2003 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jul 24, 2003

SERIAL

78278632

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Vicuron Pharmaceuticals Inc.

Entity

Corporation

State

Address

455 Gulph Road, Ste. 305, King of Prussia, PA, 19406

Country

Attorney

NameTeresa Stanek Rea

Law firm

TERESA STANEK REA BURNS DOANE SWECKER & MATHIS LLP

Docket

032796-201

Address

PO BOX 1404, ALEXANDRIA, VA 22313-1404, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJul 24, 2003

Serial Number78278632

Registration No.0

Registration DateDec 31, 1969

Status DateApr 08, 2005

Mark TypeTypeset (words/letters/numbers)

Attorney Docket032796-201

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2003

YEARS AGO

23y

CLASSES

MADRID FILINGS

—

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

9 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Apr 08, 2005

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Apr 08, 2005

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

FINAL REFUSAL WRITTEN

Sep 07, 2004

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Sep 07, 2004

FINAL REFUSAL E-MAILED

AMENDMENT FROM APPLICANT ENTERED

Aug 17, 2004

AMENDMENT FROM APPLICANT ENTERED

PAPER RECEIVED

Aug 09, 2004

PAPER RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 09, 2004

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION E-MAILED

Feb 07, 2004

NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jan 30, 2004

ASSIGNED TO EXAMINER

POSIDRAX

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Vicuron Pharmaceuticals Inc.

Other Marks by Teresa Stanek Rea

Resources

Company